Safety results of a phase 3 study of comparing paclitaxel plus 5-fluorouracil versus cisplatin plus 5-fluorouracil in chemoradiotherapy for locally advanced esophageal carcinoma (ESO-Shanghai 1).

被引：1
|
作者：
Chen, Yun
Zhao, Kuaile
Ye, Jingjun
Zhu, Zhengfei
Zhao, Weixin
Li, Ling
Zhou, Pahang
Wu, Chaoyang
Tang, Huarong
Xu, Gang
Lin, Qin
Li, Jiancheng
Xia, Yi
Li, Yunhai
Zhang, Zhen
机构：
[1] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
[2] Jiangsu Canc Hosp, Nanjing, Jiangsu, Peoples R China
[3] Jiangnan Univ, Affiliated Hosp, Wuxi, Jiangsu, Peoples R China
[4] Zhenjiang First Peoples Hosp, Zhenjiang, Jiangsu, Peoples R China
[5] Zhenjiang First Peoples Hosp, Shanghai, Peoples R China
[6] Xiamen Univ, Affiliated Hosp 1, Xiamen, Peoples R China
[7] Fujian Canc Hosp, Fuzhou, Fujian, Peoples R China
[8] Fudan Univ, Shanghai Canc Ctr, Minhang Branch, Shanghai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.4066
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4066
引用
收藏
页数：6
相关论文
共 50 条
  • [1] Final results of a phase 3 study of comparing paclitaxel plus 5-fluorouracil versus cisplatin plus 5-fluorouracil in chemoradiotherapy for locally advanced esophageal carcinoma (ESO-Shanghai 1).
    Chen, Yun
    Ye, Jingjun
    Zhu, Zhengfei
    Zhao, Weixin
    Li, Ling
    Fan, Min
    Wu, Chaoyang
    Tang, Huarong
    Xu, Gang
    Lin, Qin
    Li, Jiancheng
    Xia, Yi
    Li, Yunhai
    Zhou, Jialiang
    Zhao, Kuaile
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [2] A randomized phase 3 trial comparing paclitaxel plus 5-fluorouracil versus cisplatin plus 5-fluorouracil in Chemoradiotherapy for locally advanced esophageal carcinoma—the ESO-shanghai 1 trial protocol
    Yun Chen
    Zhengfei Zhu
    Weixin Zhao
    Ling Li
    Jinjun Ye
    Chaoyang Wu
    Huarong Tang
    Qin Lin
    Jiancheng Li
    Yi Xia
    Yunhai Li
    Jialiang Zhou
    Kuaile Zhao
    [J]. Radiation Oncology, 13
  • [3] A randomized phase 3 trial comparing paclitaxel plus 5-fluorouracil versus cisplatin plus 5-fluorouracil in Chemoradiotherapy for locally advanced esophageal carcinoma-the ESO-shanghai 1 trial protocol
    Chen, Yun
    Zhu, Zhengfei
    Zhao, Weixin
    Li, Ling
    Ye, Jinjun
    Wu, Chaoyang
    Tang, Huarong
    Lin, Qin
    Li, Jiancheng
    Xia, Yi
    Li, Yunhai
    Zhou, Jialiang
    Zhao, Kuaile
    [J]. RADIATION ONCOLOGY, 2018, 13
  • [4] Final Results of a Phase 3 Study of Comparing Paclitaxel Plus 5-Fluorouracil versus Cisplatin Plus 5-Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal Carcinoma
    Chen, Y.
    Ye, J.
    Zhu, Z.
    Zhao, W.
    Li, L.
    Fan, M.
    Wu, C.
    Tang, H.
    Xu, G.
    Lin, Q.
    Li, J.
    Xia, Y.
    Yunhai, L.
    Zhou, J.
    Zhao, K.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S28 - S28
  • [5] Comparison of concurrent chemoradiotherapy with cisplatin plus 5-fluorouracil versus cisplatin plus paclitaxel in patients with locally advanced cervical carcinoma
    Sol, Eui-Sok
    Lee, Tae Sung
    Koh, Suk Bong
    Oh, Hun Kyu
    Ye, Gi Won
    Choi, Youn Seok
    [J]. JOURNAL OF GYNECOLOGIC ONCOLOGY, 2009, 20 (01) : 28 - 34
  • [6] Neoadjuvant chemotherapy for locally advanced esophageal cancer comparing cisplatin and 5-fluorouracil versus docetaxel plus cisplatin and 5-fluorouracil: a propensity score matching analysis
    Nishiwaki, Noriyuki
    Noma, Kazuhiro
    Kunitomo, Tomoyoshi
    Hashimoto, Masashi
    Maeda, Naoaki
    Tanabe, Shunsuke
    Sakurama, Kazufumi
    Shirakawa, Yasuhiro
    Fujiwara, Toshiyoshi
    [J]. ESOPHAGUS, 2022, 19 (04) : 626 - 638
  • [7] Neoadjuvant chemotherapy for locally advanced esophageal cancer comparing cisplatin and 5-fluorouracil versus docetaxel plus cisplatin and 5-fluorouracil: a propensity score matching analysis
    Noriyuki Nishiwaki
    Kazuhiro Noma
    Tomoyoshi Kunitomo
    Masashi Hashimoto
    Naoaki Maeda
    Shunsuke Tanabe
    Kazufumi Sakurama
    Yasuhiro Shirakawa
    Toshiyoshi Fujiwara
    [J]. Esophagus, 2022, 19 : 626 - 638
  • [8] 5-FLUOROURACIL VERSUS CYTOXAN PLUS 5-FLUOROURACIL IN ADVANCED COLON ADENOCARCINOMA
    CHLEBOWSKI, R
    SILVERBERG, I
    PAJAK, T
    WEINER, J
    BATEMAN, J
    [J]. CLINICAL RESEARCH, 1978, 26 (02): : A133 - A133
  • [9] Concomitant Chemoradiotherapy with Cisplatin Plus 5-Fluorouracil for Anal Squamous Cell Carcinoma
    El-Hadaad H.A.
    Wahba H.A.
    Roshdy S.
    [J]. Journal of Gastrointestinal Cancer, 2015, 46 (2) : 156 - 160
  • [10] Recurrence Pattern Comparing Preoperative Chemoradiotherapy and Preoperative Chemotherapy with Docetaxel plus 5-Fluorouracil and Cisplatin for Advanced Esophageal Cancer
    Sugase, Takahito
    Sugimura, Keijiro
    Kanemura, Takashi
    Takeoka, Tomohira
    Yamamoto, Masaaki
    Shinno, Naoki
    Hara, Hisashi
    Omori, Takeshi
    Fujii, Yoshiaki
    Mukai, Yosuke
    Mikamori, Manabu
    Hasegawa, Shinichiro
    Haraguchi, Naotsugu
    Akita, Hirofumi
    Nishimura, Junichi
    Wada, Hiroshi
    Matsuda, Chu
    Yasui, Masayoshi
    Miyata, Hiroshi
    [J]. ONCOLOGY, 2022, : 655 - 665
12345